PRESS RELEASE published on 07/15/2024 at 07:45, 1 year 4 months ago Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights. Affluent Medical announces availability of a prospectus for trading of 6,190,831 shares in connection with a capital increase without preferential subscription rights. The AMF-approved Prospectus includes details of the Capital Increase Trading Capital Increase Affluent Medical Prospectus AMF-approved
PRESS RELEASE published on 07/15/2024 at 07:45, 1 year 4 months ago Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of Affluent Medical announces a capital increase without preferential subscription rights involving the trading of 6,190,831 shares. Edwards Lifesciences becomes a 9.21% shareholder after subscribing for €5 million. Risk factors are highlighted in the available prospectus Capital Increase Affluent Medical Prospectus Risk Factors Trading Shares
BRIEF published on 07/12/2024 at 07:50, 1 year 4 months ago Affluent Medical conclut des accords sur ses technologies de valve mitrale pour 15 millions d'euros Investissement Affluent Medical Edwards Lifesciences Technologie De Valve Mitrale Accords Financiers
BRIEF published on 07/12/2024 at 07:50, 1 year 4 months ago Affluent Medical enters into agreements on its mitral valve technologies for 15 million euros Investment Affluent Medical Edwards Life Sciences Mitral Valve Technology Financial Agreements
PRESS RELEASE published on 07/12/2024 at 07:45, 1 year 4 months ago Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences, focusing on innovative medical devices and structural heart products Affluent Medical Agreements Edwards Lifesciences Mitral Valve Technologies EUR 15M
PRESS RELEASE published on 07/12/2024 at 07:45, 1 year 4 months ago Affluent Medical conclut des accords sur ses technologies de valve mitrale moyennant un paiement initial de 15 millions d'euros. Affluent Medical conclut des accords pour ses technologies de valve mitrale avec un paiement initial de 15 millions d'euros. L'entreprise recevra des paiements pour son annexe et sa technologie de valve, ainsi qu'une participation au capital Affluent Medical Edwards Lifesciences Technologies De Valve Mitrale Paiement Initial Cardiologie Structurelle
PRESS RELEASE published on 07/12/2024 at 07:45, 1 year 4 months ago Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment. Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences. CEO expresses pride in partnership Partnership Affluent Medical Edwards Lifesciences Mitral Valve Technologies EUR 15M Upfront Payment
BRIEF published on 07/09/2024 at 17:50, 1 year 4 months ago Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.24 Droits De Vote Actions AMF Réglementation Affluent Medical
BRIEF published on 07/09/2024 at 17:50, 1 year 4 months ago Affluent Medical: Number of shares making up the share capital and total number of voting rights as of 06/30/24 Voting Rights Actions AMF Regulation Affluent Medical
BRIEF published on 07/09/2024 at 17:50, 1 year 4 months ago Bilan semestriel du contrat de liquidité d'Affluent Medical Contrat De Liquidité Bilan Semestriel Transactions Kepler Cheuvreux Affluent Medical
Published on 12/06/2025 at 00:00, 11 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 41 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 2 hours 26 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 41 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 22:15, 1 hour 56 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 59 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 13 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 5 hours 56 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 1 hour 11 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 11 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 11 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 11 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 53 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible